These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8380522)

  • 1. Parkinson's disease and the electron transport chain in postmortem brain.
    Reichmann H; Lestienne P; Jellinger K; Riederer P
    Adv Neurol; 1993; 60():297-9. PubMed ID: 8380522
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
    Hattori N; Ikebe S; Tanaka M; Ozawa T; Mizuno Y
    Adv Neurol; 1993; 60():292-6. PubMed ID: 8380521
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
    Schapira AH
    Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain.
    Cooper JM; Daniel SE; Marsden CD; Schapira AH
    Mov Disord; 1995 May; 10(3):295-7. PubMed ID: 7651446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
    Hattori N; Tanaka M; Ozawa T; Mizuno Y
    Ann Neurol; 1991 Oct; 30(4):563-71. PubMed ID: 1665052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial DNA analysis in Parkinson's disease.
    Schapira AH; Holt IJ; Sweeney M; Harding AE; Jenner P; Marsden CD
    Mov Disord; 1990; 5(4):294-7. PubMed ID: 1979656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial complex I deficiency in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1993; 60():288-91. PubMed ID: 8420145
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron-dependent enzymes in Parkinson's disease.
    Reichmann H; Janetzky B; Riederer P
    J Neural Transm Suppl; 1995; 46():157-64. PubMed ID: 8821051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1999; 80():233-7. PubMed ID: 10410727
    [No Abstract]   [Full Text] [Related]  

  • 10. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
    Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
    Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of the electron transport chain in idiopathic Parkinson's disease.
    Parker WD; Boyson SJ; Parks JK
    Ann Neurol; 1989 Dec; 26(6):719-23. PubMed ID: 2557792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study.
    Itoh K; Weis S; Mehraein P; Müller-Höcker J
    Mov Disord; 1997 Jan; 12(1):9-16. PubMed ID: 8990048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase-like activity in the Parkinson's disease brain.
    Marttila RJ; Viljanen M; Toivonen E; Lorentz H; Rinne UK
    Adv Neurol; 1990; 53():141-4. PubMed ID: 2239455
    [No Abstract]   [Full Text] [Related]  

  • 14. The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction.
    Kösel S; Egensperger R; Schnopp NM; Graeber MB
    Mov Disord; 1997 Sep; 12(5):639-45. PubMed ID: 9380043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial cardiomyopathy with cataracts and lactic acidosis: a defect in complex I (NADH-dehydrogenase) of the mitochondria respiratory chain.
    Pitkanen S; Merante F; McLeod DR; Applegarth D; Tong T; Robinson BH
    Pediatr Res; 1996 Mar; 39(3):513-21. PubMed ID: 8929874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalized dystonia.
    Reichmann H; Naumann M; Hauck S; Janetzky B
    Mov Disord; 1994 Nov; 9(6):597-600. PubMed ID: 7845398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parkinson disease--a mitochondrial myopathy?].
    Reichmann H; Janetzky B; Klinge M; Riederer P
    Nervenarzt; 1993 Apr; 64(4):215-20. PubMed ID: 8506008
    [No Abstract]   [Full Text] [Related]  

  • 20. Iron and ferritin in substantia nigra in Parkinson's disease.
    Jellinger KA; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim MB; Ben-Shachar D
    Adv Neurol; 1993; 60():267-72. PubMed ID: 8420142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.